Ex-CEO at China Biologic spearheads $3.9B buyout offer; Syneos acquires Kinapse, adding 600 staffers
→ Just weeks after Beijing-based China Biologic $CBPO booted its chairman and CEO David Gao “for cause,” the executive has bounced back at …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.